A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)

Abstract

Our study suggested a new and reliable prognostic signature that has a significant implication in predicting overall survival for LUAD patients and may help with early diagnosis and making effective clinical decisions regarding potential individual treatment.